SciELO - Scientific Electronic Library Online

 
vol.22 issue5Media tracheal stenosis for prolonged intubationLung cancer: some epidemiologic, diagnoses and treatment considerations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Archivo Médico de Camagüey

On-line version ISSN 1025-0255

Abstract

GARCIA RODRIGUEZ, Miguel Emilio et al. Use of intrapleural recombinant streptokinase in a pregnant woman with pleural empyema. AMC [online]. 2018, vol.22, n.5, pp.767-780. ISSN 1025-0255.

Background:

pneumonia complicates 0,78-2,7 per 1 000 pregnancies placing the mother and the fetus at risk. Empyema as a complication of pneumonia in a pregnant patient adds a high rate of morbidity and mortality to the mother and the fetus if one does not act quickly.

Objective:

to present the case of a pregnant woman of 33 weeks who developed a pleural empyema resulting from acquired pneumonia.

Clinical case:

33-week gestated patient, asthmatic admitted to the intensive care unit of the University Hospital Manuel Ascunce Domenech with the diagnosis of severe pneumonia acquired in the community complicated with para-pneumonic effusion, which evolved into empyema. It was treated with a thoracotomy tube and fibrinolytic therapy, with good clinical and radiological evolution.

Conclusions:

Recombinant streptokinase can be used safely and effectively for the management of PE, as an intrapleural fibrinolytic agent, during pregnancy.

Keywords : PREGNANCY COMPLICATIONS; STREPTOKINASE/therapeutic use; EMPYEMA, PLEURAL/DRUG THERAPY; EMPYEMA, PLEURAL/ complications; FIBRINOLYTIC AGENTS/therapeutic use.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )